Clinical Microbiology and Infection

Article	Citations
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines	657
Lysosomal alkalization to potentiate eradication of intra-osteoblastic Staphylococcus aureus in the bone and joint infection setting	577
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays	518
Abandoned trials in infection diseases and clinical microbiology: a call for action	486
Measuring the impact of hospitalisation for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020-2023)	334
Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans: author's response	329
The risk of drug-induced liver injury associated with flucloxacillin: a nationwide, entropy-balanced cohort study	306
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20	288
Revisiting diagnostics: Rapid Diagnosis of Neurological Infections	268
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – Author’s reply	258
Clinical Microbiology and Infection will recognize excellent research by early-career scientists	238
Methicilin-resistant Staphylococcus aureus in the community—time to take action	233
Revisiting diagnostics: the reliability of culture-independent detection of microbial pathogens by DNA sequencing needs improvement	215
Five versus seven days of nitrofurantoin for urinary tract infections in women with diabetes: a retrospective cohort study	204
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	174
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples	155
Industry-sponsored research funding to infectious disease physicians in the United States between 2013 and 2021	146
Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients	143
Vaccines alone will not prevent COVID-19 outbreaks among migrant workers—the example of meat processing plants	142
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study	141
A dosing nomograph for cerebrospinal fluid penetration of meropenem applied by continuous infusion in patients with nosocomial ventriculitis	138
Re: ‘The renal safety of a single dose of gentamicin in patients with sepsis in the emergency department’ - Author’s reply	136
The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients	130
Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?	127
Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial	116

Mycotic aneurysm of the infrarenal abdominal aorta infected by Mycoplasma hyorhinis diagnosed with direct 16S ribosomal DNA sequencing	115
Limitations of classification and regression tree analysis in vancomycin exposure–response relationship studies: insights from data simulation	110
Re: Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil by Ranzani et al.	107
Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination	106
Re: Accelerating clinical trial implementation in the context of the COVID-19 pandemic by Diallo et al	104
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections	103
Re: ‘Seven versus 14-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales’ by Molina et al.	103
Re: ‘the unique COVID-19 presentation of patients with B cell depletion’ by Belkin et al.	100
Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance	99
SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India	99
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors–a cross-sectional study in seven German university hospitals from 2014 to 2018	98
Title Page	97
Publishing Information	96
Title Page	93
Outside Front Cover	93
Prophylaxis for COVID-19: a systematic review	90
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021	89
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi	86
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial	80
‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply	77
Clinical and laboratory features of Strongyloides stercoralis infection at diagnosis and after treatment: a systematic review and meta-analysis	77
Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other variants of concern and impact on diagnostic testing strategy	76
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study	76
Characteristics, management and outcome of Herpes Simplex and Varicella-Zoster virus encephalitis: a multicentre prospective cohort study	75
Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis	74
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections	72
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study	72
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study	71
Selective reporting of antibiotic susceptibility testing results: less is more	71
In vitro susceptibility to delafloxacin of Pseudomonas aeruginosa with resistance to other quinolones (ciprofloxacin and levofloxacin)	68
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir	68
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	68
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia	67
Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.	67
Development and validation of a novel death risk stratification scale in patients with hemorrhagic fever with renal syndrome: a 14-year ambispective cohort study	65
The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: a cohort analysis	65
A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality	64
Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine	64
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing	62
Intravenous metronidazole for fulminant Clostridioides difficile infection	61
A case of fatal monkeypox infection: necropsy and molecular findings, with some considerations related to clinical management	61
Penicillin V versus amoxicillin for pneumonia in children—a Swedish nationwide emulated target trial	60
Lower (1,3)-β-D-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains: author's response	59
Quantifying the long-term effects of measles infection—a retrospective cohort study	58
Expanding evidence for shortened treatment of latent tuberculosis infection: progress, not perfection	56
Scientific misconduct in infectious diseases—European Society of Clinical Microbiology and Infectious Diseases survey	54
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections	54
Trends in antimicrobial resistance of bacterial isolates in China, 2014 to 2022	53
Occurrence of in vivo carbapenem-resistant Campylobacter coli mediated by porA point mutation and overexpression of blaOXA-489 under meropenem treatment	53
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)	53

Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis	52
Tuberculosis treatment monitoring tests during routine practice: study design guidance	52
Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study	51
Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19	51
Systematic review and meta-analysis of the accuracy of McIsaac and Centor score in patients presenting to secondary care with pharyngitis	51
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern	51
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe	51
Characteristics and long-term prognosis of Danish residents with a positive intrathecal antibody index test for herpes simplex virus or varicella-zoster virus compared with individuals with a positive	50
Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients	48
Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated coho	48
Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model	48
Development of a EUCAST disk diffusion method for the susceptibility testing of rapidly growing anaerobic bacteria using Fastidious Anaerobe Agar (FAA): a development study using Bacteroides species	48
Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria	48
Early switch from intravenous to oral anti-microbial therapy in infectious diseases	48
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response	47
Comparison of influenza hospitalization outcomes among adults, older adults, and octogenarians: a US national population-based study	47
Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study	47
Antibiotic stewardship in the emergency department: not to be overlooked	46
Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis	46
Humoral serological response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation	46
Identification of gaps in the performance of routine microscopy for the diagnosis of parasitic infections revealed by the Dutch laboratory quality assessment scheme	45
The world health organization pandemic agreement draft: considerations by the European Society of Clinical Microbiology and Infectious Diseases Emerging Infections Task Force	44
Guideline-based intervention improves the quality of antibiotic allergy registration in a hospital setting	44
Analyzing COVID-19 vaccine efficacy in vulnerable communities: efforts beyond addressing vaccine inequity	44
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections	43
Challenges towards serologic diagnostics of emerging arboviruses	43
Thank you to our peer-reviewers: CMI 2022	43
Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT)	43
Follow-up blood cultures do not reduce mortality in hospitalized patients with Gram-negative bloodstream infection: a retrospective population-wide cohort study	43
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness	42
Re: ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’ by Bartoletti et al	42
Rituals and behaviours in the operating theatre and preventing infection. Using the evidence and consensus opinion to provide practical advice	42
Analytical interference with most current commercial HIV molecular assays in patients treated by idecabtagene vicleucel, a recently approved lentivirus-based chimeric antigen receptor T-cell therapy	42
Attributable mortality of antibiotic resistance in gram-negative infections in the Netherlands: a parallel matched cohort study	41
The prognostic value of serological titres in chronic Q fever: treat the patient, not the laboratory data	41
SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study	40
The COVID-19 vaccine health pass fraud in France	40
Gut microbiome diversity and composition in individuals with and without extended-spectrum β-lactamase-producing Enterobacterales carriage: a matched case–control study in infectious diseases departme	39
Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship	39
The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research	39
Re: ‘Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe’ by Lange et al.	39
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models	39
Treatment of Coxiella burnetii endocarditis with hydroxychloroquine. Is it evidence-based?	38
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	38
Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value	38
Persistence of the neutralizing antibody response after SARS-CoV-2 infection	38
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	38
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)	38
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents	37
Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples	37
Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients	37
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples	37
The ESCMID ethics advisory committee (EEAC): purpose and challenges	36
COVID-19 in special populations	36
Prevalence and risk factors of mcr-1-positive volunteers after colistin banning as animal growth promoter in China: a community-based case–control study	36
Searching high and low: call for a joint ESPID-EUCAST survey on dosage of antibacterial agents in children–part one	36
Which are the best coronavirus disease 2019 vaccines?	36
“Unite for safety – clean your hands”: the 5 May 2022 World Health Organization SAVE LIVES: Clean Your Hands campaign	36
Who should receive oral antiviral therapy for severe acute respiratory syndrome coronavirus 2 infection in the omicron era? Choose wisely	35
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield	35
Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.	35
Omicron variant: assessing the duration of viral shedding and its implications	35
Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.	35
Diagnostic accuracy of rapid antigen tests in cerebrospinal fluid for pneumococcal meningitis: a systematic review and meta-analysis	35
A man with a prepared mind – in commemoration of the bicentenary of the birth of Louis Pasteur 1822 - 2022	35
Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al	34
Minimizing nephrotoxicity during multidrug-resistant tuberculosis treatment by the stepwise de-escalation of second-line injectables dosing intervals	34
Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update	34
Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience	34
Short-course versus long-course antibiotic treatment for uncomplicated vancomycin-resistant enterococcal bacteraemia: a retrospective multicentre cohort study	34
Ceftaroline for bloodstream infections caused by methicillin-resistant Staphylococcus aureus: a multicentre retrospective cohort study	34
Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia	33
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study	33
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023	33
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission	33
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis	33
Does dose reduction of renally cleared antibiotics in patients with impaired renal function lead to adequate drug exposure? A systematic review	33
Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections	33
Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections	32
Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis	32

Value of lipocalin 2 as a potential biomarker for bacterial meningitis	32
Update on imaging in fever and inflammation of unknown origin: focus on infectious disorders	31
Primary odontogenic onset invasive mucormycosis—an under recognized clinical entity	31
The impact of social restrictions on the incidence and microbiology of peritonsillar abscess: a retrospective cohort study	31
Evidence-based dosing of convalescent plasma for COVID-19 in future trials	31
Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?	31
Emergence of mcr-1, mcr-3 and mcr-8 in clinical Klebsiella pneumoniae isolates in Taiwan	31
In vitro susceptibility of fosfomycin in Aerococcus spp. isolated from urine samples	31
Antibiotic use from formal and informal healthcare providers in the Democratic Republic of Congo: a population-based study in two health zones	30
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	30
Re: ‘Post-COVID-19 chronic symptoms’ by Davido et al.	30
Comparison of three sample types for performing LDBio Aspergillus immunochromatographic technology lateral flow assay for IgG/IgM antibody detection in chronic aspergillosis	29
Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study	29
Performance of Xpert Ultra nasopharyngeal swab for identification of tuberculosis deaths in northern Tanzania	29
Resurgence of syphilis in 2022 amongst heterosexual men and women in Osaka, Japan	29
Evaluation of susceptibility testing methods for Burkholderia cepacia complex: a comparison of broth microdilution, agar dilution, gradient strip and EUCAST disc diffusion	29
Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May–June 2020): implications for a testing protocol in asymptomatic individuals and es	29
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	29
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	29
COVID-19 vaccination in Israel	29
Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile	29
COVID-19 associated mucormycosis: a life-threatening complication in patients admitted with severe to critical COVID-19 from Pakistan	28
ARCHITECT Chagas® as a single test candidate for Chagas disease diagnosis: evaluation of two algorithms implemented in a non-endemic setting	28
Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategies	28
Bacterial load in cerebrospinal fluid predicts unfavourable outcome in pneumococcal meningitis: a prospective nationwide cohort study	28
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition	28
Re: “HANCEK” infective endocarditis: a case for including Neisseria elongata in the HACEK group	27
Acceptance of coronavirus disease 2019 vaccine among health-care personnel in India: a cross-sectional survey during the initial phase of vaccination	27
Association between male circumcision and human papillomavirus infection in males and females: a systematic review, meta-analysis, and meta-regression	27
Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children	26
Antimicrobial stewardship challenges in extracorporeal membrane oxygenation	26
Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland	26
Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey	26
More evidence needed before upper respiratory tract point-of-care microbiological testing for respiratory infections is used in primary care	26
Impact of susceptible, increased exposure, a new definition of the former intermediate susceptibility category, introduced by the European Committee for Antimicrobial Susceptibility Testing on antimic	26
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?	26
Urinary tract infections in pregnancy	26
A novel multiplex real-time polymerase chain reaction for the molecular diagnosis of metacestode infections in human patients	26
First detection of the emerging vancomycin-resistant Enterococcus faecium vanA-ST1299-CT1903 in Austria	26
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	26
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study	26
Candidate anti-tuberculosis medicines and regimens under clinical evaluation	25
Assessment of in vitro antimicrobial activity of clindamycin metabolites against Staphylococcus species	25
Management of uncomplicated urinary tract infection in the post-antibiotic era: select non-antibiotic approaches	25
Mission (im)possible: elimination of tuberculosis	25
Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection	24
Non-biomedical factors affecting antibiotic use in the community: a mixed-methods systematic review and meta-analysis	24
Appeal from the European tuberculosis reference laboratory network (ERLTB-Net) for improving the diagnosis of infections due to nontuberculous mycobacteria	24
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	24
A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathways	24
Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis	24
Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized co	24
Re: ‘Cost–benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for Vancomycin’ by Lee et al.	24
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	24
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation	23
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?	23
Real-time dermoscopy of numerous mites crawling on the crusted scabies	23
In vivo evolution to high-level cefiderocol resistance of NDM-1–producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission	23
Re: Surveillance of Mycobacterium tuberculosis drug resistance and epidemiology in Southwest China, a China CDC pilot study	23
Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial	23
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	23
Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B	23
Use of biomarkers to individualize antimicrobial therapy duration: a narrative review	23
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review	23
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain	22
PRAISE: providing a roadmap for automated infection surveillance in Europe	22
External validation of WGS-based antimicrobial susceptibility prediction tools, KOVER-AMR and ResFinder 4.1, for Escherichia coli clinical isolates	22
Clinical phage microbiology: a narrative summary	22
Update on SARS-CoV-2 seroprevalence: regional and worldwide	22
Guidance on reporting the use of natural language processing methods	22
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	22
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	22
Antifungal activity of nitroxoline against Candida auris isolates	22
Elevated body mass index is associated with an increased risk of infectious disease admissions and mortality: a mendelian randomization study	22
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	22
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation	22
Update on the diagnosis of tuberculosis	21
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	21
A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients	21
Comparison of four assays for human papillomavirus detection in the anal canal	21
Use of artificial intelligence for tailored routine urine analyses	21
Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway	21
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study	21
Sample pooling: burden or solution?	21
Information technology aspects of large-scale implementation of automated surveillance of healthcare-associated infections	21
How to interpret and use COVID-19 serology and immunology tests	21
The Shorter Is Better movement: past, present, future	21
Characterizing the inclusion of pregnant and breastfeeding people in infectious diseases randomized controlled trials: a targeted literature review	21
Clinical microbiology and infection: an open call for editorial interns	21
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort	21
External validation of the PRIORITY model in predicting COVID-19 critical illness in vaccinated and unvaccinated patients	21
Dynamics and predisposition of respiratory viral co-infections in children and adults	21
Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial	21
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	21
Viral dynamics of SARS-CoV-2 in immunocompromised patients	21